TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 7.2B
Gross Profit 7.2B 100.00%
Operating Income 2.0B 27.74%
Net Income 1.5B 20.42%

Balance Sheet Metrics

Total Assets 30.5B
Total Liabilities 12.6B
Shareholders Equity 17.9B
Debt to Equity 0.71

Cash Flow Metrics

Revenue & Profitability Trend

Inventurus Knowledge Income Statement From 2022 to 2025

Metric2025202420232022
Revenue i26.6B18.2B10.3B7.6B
Cost of Goods Sold i7.5M7.1M00
Gross Profit i26.6B18.2B10.3B7.6B
Gross Margin % i100.0%100.0%100.0%100.0%
Operating Expenses
Research & Development i----
Selling, General & Administrative i-1.4B456.6M400.8M
Other Operating Expenses i4.0B3.4B794.1M404.2M
Total Operating Expenses i4.0B4.7B1.3B805.0M
Operating Income i6.6B4.6B3.7B2.8B
Operating Margin % i24.7%25.4%35.9%36.2%
Non-Operating Items
Interest Income i-300.0M284.0M202.1M
Interest Expense i897.6M600.9M53.6M64.5M
Other Non-Operating Income----
Pre-tax Income i6.1B4.4B3.6B2.7B
Income Tax i1.2B711.8M541.2M355.5M
Effective Tax Rate % i19.8%16.1%15.1%13.2%
Net Income i4.9B3.7B3.1B2.3B
Net Margin % i18.2%20.4%29.6%30.5%
Key Metrics
EBITDA i8.1B5.6B4.2B3.2B
EPS (Basic) i₹29.20₹21.59₹17.79₹13.58
EPS (Diluted) i₹28.62₹21.59₹17.79₹13.58
Basic Shares Outstanding i166458562171573159171573159171573159
Diluted Shares Outstanding i166458562171573159171573159171573159

Income Statement Trend

Inventurus Knowledge Balance Sheet From 2022 to 2025

Metric2025202420232022
Assets
Current Assets
Cash & Equivalents i1.8B1.4B1.2B1.5B
Short-term Investments i382.5M3.4B4.0B2.0B
Accounts Receivable i5.3B3.5B1.5B972.8M
Inventory i07.5M00
Other Current Assets331.4M17.4M-47.8M
Total Current Assets i7.8B9.0B7.0B4.6B
Non-Current Assets
Property, Plant & Equipment i1.2B613.6M378.0M336.4M
Goodwill i28.7B28.5B13.4M5.3M
Intangible Assets i4.8B5.1B13.4M5.3M
Long-term Investments-000
Other Non-Current Assets320.4M---
Total Non-Current Assets i22.7B21.3B2.9B3.3B
Total Assets i30.5B30.3B9.9B7.9B
Liabilities
Current Liabilities
Accounts Payable i759.6M677.4M216.9M96.5M
Short-term Debt i2.7B4.0B130.1M139.7M
Current Portion of Long-term Debt----
Other Current Liabilities1.0B---
Total Current Liabilities i5.2B7.9B1.1B828.2M
Non-Current Liabilities
Long-term Debt i5.9B9.1B393.4M512.2M
Deferred Tax Liabilities i1.3B1.5B00
Other Non-Current Liabilities----
Total Non-Current Liabilities i7.4B10.8B447.3M576.3M
Total Liabilities i12.6B18.7B1.6B1.4B
Equity
Common Stock i170.2M169.2M168.4M168.1M
Retained Earnings i-9.3B7.3B5.6B
Treasury Stock i----
Other Equity----
Total Shareholders Equity i17.9B11.6B8.3B6.5B
Key Metrics
Total Debt i8.6B13.1B523.5M651.9M
Working Capital i2.6B1.1B5.8B3.8B

Balance Sheet Composition

Inventurus Knowledge Cash Flow Statement From 2022 to 2025

Metric2025202420232022
Operating Activities
Net Income i6.1B4.4B3.6B2.7B
Depreciation & Amortization i----
Stock-Based Compensation i277.3M85.6M25.1M9.3M
Working Capital Changes i-3.9B-2.0B-435.5M-224.2M
Operating Cash Flow i3.0B2.7B3.3B2.5B
Investing Activities
Capital Expenditures i-241.8M-263.2M-75.0M-107.4M
Acquisitions i-644.5M-14.1B00
Investment Purchases i-1.1M-1.4B-3.6B-3.0B
Investment Sales i3.2B4.1B1.9B2.1B
Investing Cash Flow i2.4B-11.7B-1.8B-936.5M
Financing Activities
Share Repurchases i-229.6M-1.4M-1.1B-1.3M
Dividends Paid i--1.7B--442.6M
Debt Issuance i010.3B00
Debt Repayment i-3.3B-332.8M00
Financing Cash Flow i-2.8B8.4B-1.2B-400.8M
Free Cash Flow i2.8B1.8B2.8B2.2B
Net Change in Cash i2.6B-644.8M234.1M1.2B

Cash Flow Trend

Inventurus Knowledge Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 48.62
Forward P/E 31.60
Price to Book 14.63
Price to Sales 9.51

Profitability Ratios

Profit Margin 19.61%
Operating Margin 28.35%
Return on Equity 27.16%
Return on Assets 15.93%

Financial Health

Current Ratio 1.50
Debt to Equity 47.81

Per Share Data

EPS (TTM) ₹32.35
Book Value per Share ₹107.53
Revenue per Share ₹165.80

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
iks260.5B48.6214.6327.16%19.61%47.81
Sagility India 209.4B32.132.566.47%11.31%16.82
Indegene 138.0B31.745.2615.55%14.89%3.88
JSW Steel 602.5M1,012.501.230.27%-9.49%41.10
Sun Pharmaceutical 3.9T37.285.3715.08%19.29%3.26
Divi's Laboratories 1.6T69.8010.7414.64%23.89%0.03

Financial data is updated regularly. All figures are in the company's reporting currency.